SCHEMBL2558035

SCHEMBL2558035

CCN(C(=O)CCl)c1ccccn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
POLB P06746 1/20 0.48
GAA P10253 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
TSHR P16473 1/20 0.47
THRB P10828 1/20 0.45
TRPM8 Q7Z2W7 3/20 0.45
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
TP53 P04637 2/20 0.44
LMNA P02545 1/20 0.44
NPC1 O15118 1/20 0.43
JAK2 O60674 1/20 0.43
RAB9A P51151 1/20 0.43
PAX8 Q06710 1/20 0.43
MAPT P10636 1/20 0.43
OPRM1 P35372 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL666126 0.87 OPRM1 (0.53) MEN1KMT2APOLBGAASMN1; SMN2
SCHEMBL23355845 0.85 MEN1 (0.51) MEN1KMT2APOLBGAASMN1; SMN2
SCHEMBL5141980 0.85 MEN1 (0.51) MEN1KMT2APOLBGAASMN1; SMN2
SCHEMBL4162403 0.84 MEN1 (0.50) MEN1KMT2APOLBGAASMN1; SMN2
SCHEMBL5508940 0.83 POLB (0.60) MEN1KMT2APOLBGAASMN1; SMN2
SCHEMBL2562392 0.81 POLB (0.51) MEN1KMT2APOLBGAASMN1; SMN2
SCHEMBL4036418 0.81 GAA (0.54) MEN1KMT2APOLBGAASMN1; SMN2
SCHEMBL2700566 0.80 POLB (0.48) MEN1KMT2APOLBGAASMN1; SMN2
SCHEMBL7715832 0.80 POLQ (0.50) MEN1KMT2APOLBGAASMN1; SMN2
SCHEMBL30528370 0.80 POLB (0.50) MEN1KMT2APOLBGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011132048-A1 HETEROARYL COMPOUNDS AS PDE10A INHIBITORS GLENMARK PHARMACEUTICAL S.A. (CH) 2011-10-27 WO disclosed
WO-2011132048-A1 HETEROARYL COMPOUNDS AS PDE10A INHIBITORS GLENMARK PHARMACEUTICAL S.A. (CH) 2011-10-27 WO disclosed
EP-2010493-A2 PYRIDYL AMIDE T-TYPE CALCIUM CHANNEL ANTAGONISTS Merck & Co., Inc. (US) 2009-01-07 EP disclosed
WO-2007120729-A2 PYRIDYL AMIDE T-TYPE CALCIUM CHANNEL ANTAGONISTS MERCK & CO., INC. (US) 2007-10-25 WO disclosed